94 related articles for article (PubMed ID: 4808371)
1. [Clinico-immunological characteristics of measles in children vaccinated with a live measles vaccine].
Smorodinova IP; Shikina ES
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():102-8. PubMed ID: 4808371
[No Abstract] [Full Text] [Related]
2. [Increase of immunoglobulins G, A, M, D and specific antibodies in a group of children vaccinated against measles by Czechoslovak live vaccine Movivac Sevac].
Wiedermannová D; Wiedermann D; Bozdĕchová M; Hatiarová Z
Cas Lek Cesk; 1973 Mar; 112(10):297-301. PubMed ID: 4691543
[No Abstract] [Full Text] [Related]
3. [Clinical and immunological reactions after measles vaccination with cleavage vaccine and live vaccine].
Stehr K; Enders G; Suschke HJ; Spiess H
Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):383-7. PubMed ID: 5523685
[No Abstract] [Full Text] [Related]
4. [Laboratory surveillance of measles. Chile, 1992-1995].
Vicente M; Yung V; Fasce R; Lezano V; Vera L; Villagra E; Espiñeira E
Rev Med Chil; 1998 Jan; 126(1):107-14. PubMed ID: 9629761
[TBL] [Abstract][Full Text] [Related]
5. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
Linnemann CC; Dine MS; Roselle GA; Askey PA
Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
[TBL] [Abstract][Full Text] [Related]
6. [Specific features of measles in vaccinated children].
Loseva AG; Peĭzner EM
Vopr Okhr Materin Det; 1978 Sep; 23(9):49-50. PubMed ID: 716292
[No Abstract] [Full Text] [Related]
7. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and immunological prospective study of the measles live virus vaccine].
Sujoy E; Blaksley JC; Shepherd G; Simsolo V; Palais L; Pizzia A; Becker D; Behar M; Morgenstern O
Arch Argent Pediatr; 1966; 63(7):260-5. PubMed ID: 5990418
[No Abstract] [Full Text] [Related]
9. Increase of circulating CD8+CD57+ lymphocytes after measles infection but not after measles vaccination.
Aronsson B; Troye-Blomberg M; Smedman L
J Clin Lab Immunol; 2004-2005; 53():1-12. PubMed ID: 16805321
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics of reactions of children to measles vaccination and course of measles in vaccinated children].
Stepina NG; Kravchenko AS; Onishchenko TE; Shlifer RN; Cheaureli EP
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():230-4. PubMed ID: 5860944
[No Abstract] [Full Text] [Related]
11. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
[No Abstract] [Full Text] [Related]
12. [Indices of humoral antimeasles postvaccinal immunity].
Tikhonova NT; Prokudina IuA; Khrometskaia TM; Potemkina EE
Vopr Virusol; 1975; (3):287-92. PubMed ID: 1162947
[TBL] [Abstract][Full Text] [Related]
13. A clinical and serologic study of 103 children with measles vaccine failure.
Cherry JD; Feigin RD; Shackelford PG; Hinthorn DR; Schmidt RR
J Pediatr; 1973 May; 82(5):802-8. PubMed ID: 4698954
[No Abstract] [Full Text] [Related]
14. [Several indices of humoral anti-measles immunity in children, previously immunized with live measles vaccine, who have developed measles].
Tikhonova NT; Khrometskaia TM; Livanova LV; Poliakova TA; Azarova SA
Vopr Virusol; 1978; (3):322-7. PubMed ID: 695522
[TBL] [Abstract][Full Text] [Related]
15. Studies on the combined use of killed and live measles vaccines. I. Correlation between antibody titers following injection of killed vaccine and clinical reactions after live vaccine inoculation.
Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
Biken J; 1965 Jun; 8(2):73-9. PubMed ID: 5837766
[No Abstract] [Full Text] [Related]
16. Measles epidemiology and its implications for a vaccination programme in Oman.
Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S
East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622
[TBL] [Abstract][Full Text] [Related]
17. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
Gerike E; Tischer A
Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
[TBL] [Abstract][Full Text] [Related]
18. [Immunoelectrophoretic studies of blood serum of children with measles].
Pawlicka-Domańska Z; Sliwińska-Przyjemska H
Przegl Epidemiol; 1972; 26(2):173-8. PubMed ID: 5070974
[No Abstract] [Full Text] [Related]
19. Seroconversion after measles vaccination in infants and children.
Seghal S; Sharma RS; Das A; Sebastian M; Arora RR
J Commun Dis; 1983 Jun; 15(2):75-9. PubMed ID: 6630988
[No Abstract] [Full Text] [Related]
20. Estimation of the time-dependent vaccine efficacy from a measles epidemic.
Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K
Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
